| Literature DB >> 29138696 |
Gabriele Falzarano1, Antonio Piscopo2, Predrag Grubor3, Giuseppe Rollo4, Antonio Medici1, Valerio Pipola5, Michele Bisaccia6, Auro Caraffa6, Elizabeth Mary Barron7, Francesco Nobile8, Raffaele Cioffi1, Luigi Meccariello6.
Abstract
Orthopedic implants have become essential components of modern medicine. The risk of infection of total hip arthroplasty (THA) is 1.5%-2%. Are the C-reactive protein (CRP), the erythrocyte sedimentation rate (ESR), and procalcitonin (PCT) good markers for THA infection screenings? From February 2009 to December 2012 at our Department of Orthopedics and Traumatology, 1248 patients were treated with THA. No prosthesis was cemented. All patients received antibiotic prophylaxis. All patients were discharged approximately 7.4 days after surgery with this clinical and radiographic follow-up program at 15 days and 1, 3, 6, 12, 24, and 36 months after surgery. Blood samples to determine ESR, CRP, and PCT values were taken at 1 hour before surgery and 15 days and 1, 3, 6, 12, 24, and 36 months after surgery. During follow-ups there were 22 cases of THA infections; according the Widmer classification, infections are hematogenous ones in 16 cases, late chronic ones in 5 cases, and early postoperative ones in 1 case. In all cases the three markers were considered positive; in 6 cases there were no radiological signs of septic loosening. ESR, CRP, and PCT proved to have a greater diagnostic accuracy than X-rays in predicting late chronic and early postoperative infections. These markers are valuable support for the surgeon in monitoring the prosthetic implant lifespan.Entities:
Year: 2017 PMID: 29138696 PMCID: PMC5613705 DOI: 10.1155/2017/9679470
Source DB: PubMed Journal: Adv Orthop ISSN: 2090-3464
Description of population.
| Description | |
|---|---|
| Numbers of patients | 1248 |
| Average age of patients | 73,40 years |
| Range of age | 21–85 years |
| Gender ratio (M : F) | 1,15 (658 : 570) |
| Diseases ratio (arthritis/fractures) | 2,59 (900 : 348) |
| ASA I: 338 (27,08%) | |
| ASA physical status classification system | ASA II: 792 (63,46%) |
| ASA III: 118 (9,46%) | |
| Number of patients who needed intensive care after surgery | 59 (4,73%) |
| Average days in intensive care | 2,8 |
| Range of days in intensive care | 1–6 |
| Average days of hospitalization | 6,7 |
| Range of days of hospitalization | 4–15 |
| Anterior approach: 40 (3,20%) | |
| Surgical approach | Laterolateral approach: 926 (74,20%) |
| Posterolateral approach: 282 (22,6%) | |
| Average length of surgical wound | 11.6 cm |
| Range of length of surgical wound | 10.3–16.5 cm |
| Average length of surgery | 56.3 minutes |
| Range of length of surgery | 48.3–90.8 minutes |
| General anesthesia | 523 (41,19%) |
| Spinal anesthesia | 725 (58,81%) |
Number of comorbidities (%).
| Respiratory disease | 256 (20,51%) |
| Renal disease | 108 (8,65%) |
| Diabetes mellitus | 72 (5,77%) |
| Rheumatoid disease | 243 (19,47%) |
| Parkinson disease | 16 (1,28%) |
| Severe mental deterioration in old age | 3 (0,24%) |
| Paget disease | 12 (0,96%) |
| Current smokers | 160 (12,82%) |
| Enteral steroids | 281 (22,51%) |
|
| |
| Number of comorbidities in patient | |
|
| |
| 1 | 476 |
| 2 | 894 |
| ≥3 | 191 |
Number of perioperative complications.
| Number (%) | |
|---|---|
| Chest infection | 24 (1,92%) |
| Cardiac failure | 60 (4,80%) |
| DVT/PE | 27 (2,16%) |
| Urinary tract infection | 168 (13,46%) |
| Gastrointestinal haemorrhage | 27 (2,16%) |
| Myocardial infarction | 54 (4,33%) |
| Stroke | 27 (2,16%) |
| Number of complications | |
| 1 | 170 |
| 2 | 89 |
| ≥3 | 128 |
| Total of complications | 387 |
| Died before the second year of follow-up | 4 |
Figure 1Trend of ESR during 36 months of follow-up.
Figure 2Trend of CRP during 36 months of follow-up.
Figure 3Trend of PCT during 36 months of follow-up.
Description of THA infection.
| Infection category | Typical onset after surgery | Type | Signs and symptoms | Representative microorganism |
|---|---|---|---|---|
| Early postoperative | ≤2–4 weeks | Acute (type I) | Persistent pain after surgery, fever, redness, swelling after surgery |
|
| Late chronic | ≥1 month | Chronic (type II) | Insidious onset, persisting pain after surgery | Coagulase-negative staphylococci, |
| Hematogenous | >2 years | Acute (type III) | Fever, pain, redness, swelling after a long period of wellness | Streptococci, |